This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of VYVANSE 30 MG CAPSULE 100S, with a ceiling value of $1,166.06 and a period of performance extending to June 23, 2025. The contract is a Firm Fixed Price Delivery Order, without any set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant...
This federal contract award to Amerisourcebergen Drug Corp Corporate Office Division, a major pharmaceutical distributor, is a Delivery Order valued at $2,785.90 from the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the supply of VYVANSE 50 MG CAPSULE 100S, a prescription medication, to support various government healthcare programs and military treatment facilities. This award is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the provision of VYVANSE 50 MG CAPSULE 100S. The award has a ceiling value of $1,427.48 and is a Firm Fixed Price Delivery Order contract. The contract has an ultimate completion date of January 16, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999 through November...
The U.S. Defense Logistics Agency (DLA) awarded a $1,293.00 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp for the provision of 4565519574 - VYVANSE 50 MG CAPSULE 100S. This award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a comprehensive range of pharmaceutical and medical supplies to support military treatment programs and...
This federal contract award to Amerisourcebergen Drug Corp, a for-profit pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, with a ceiling value of $3,516.78, is for the delivery of 4,566,526,139 units of the pharmaceutical product VYVANSE 30 MG CAPSULE 100S. The contract is a Firm Fixed Price Delivery Order with a period of performance through November 25, 2024. This award is part of a larger Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,658.67, is a delivery order for the supply of VYVANSE 40 MG CAPSULE 100S, a prescription medication. The contract has a ceiling value of $1,658.67 and a period of performance through December 27, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the...
This federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of VYVANSE 40 MG CAPSULE 100S. The contract, valued at $3,339.12, was awarded by the Defense Logistics Agency (DLA) Troop Support Medical and does not have a set-aside designation. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and DLA Troop Support Medical, valued up to $999,999,999, for the supply of a comprehensive range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $4,033.44 firm fixed-price delivery order is for the supply of VYVANSE 10 MG CAPSULE 100S, a prescription medication. The contract has an ultimate completion date of August 16, 2024 and was awarded on August 15, 2024. This award is likely part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the...
This federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract, valued at $1,986.08, is for the delivery of VYVANSE 60 MG CAPSULE 100S, a prescription medication. The contract is a Delivery Order with a Firm Fixed Price pricing type, and the Ultimate Completion Date is October 17, 2024. There is no set-aside designation indicated for this award. In addition to this specific...
This federal contract award, valued at $3,148.98, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of VYVANSE 50 MG CAPSULE 100S, a prescription medication, with a completion date of October 30, 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at...